Talon Therapeutics, Inc. reports on the first quarterback 2013 Financial year results

Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Year Results ... Posaconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelf...


Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Year Results
… Posaconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin). In a similar manner the simultaneous use of strong CYP3A-Inductors should be avoided (eg, dexamethasone, phenytoin, carbamazepine, be rifampin …
Read more on Yahoo! New Zealand News


Leave a Reply